Argo Blockchain PLC Announces June Operational Update
June Operational Update LONDON, UNITED KINGDOM / ACCESSWIRE / July 5, 2024 / Argo Blockchain plc, a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), is pleased to provide the following operational update for June 2024. During the month of June, the Company mined 44 Bitcoin or Bitcoin Equivalents (together, "BTC"), or 1.5 BTC per day.
Trident Royalties PLC Announces Publication of Scheme Document
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. RECOMMENDED CASH ACQUISITION of TRIDENT ROYALTIES PLC by DETERRA GLOBAL HOLDINGS PTY LTD (a direct wholly owned subsidiary of Deterra Royalties Limited) to be effected by means of a scheme of arrangement under Part 26 of the Companies Act 2006 PUBLICATION OF SCHEME DOCUMENT LONDON, UNITED KINGDOM / ACCESSWIRE / July 4, 2024 / On 13 June 2024, the boards of Deterra Global Holdings Pty Ltd ("Bidco") and Trident Royalties Plc ("Trident") announced that they had agreed the terms of a recommended cash acquisition of Trident by Bidco pursuant to which Bidco will acquire the entire issued and to be issued share capital of Trident (the "Acquisition").
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 4
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / July 4, 2024 / The Company announces that on 03 July 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
i3 Energy PLC Announces Share Capital Reduction
EASTLEIGH, UK / ACCESSWIRE / July 4, 2024 / i3 Energy plc (AIM:I3E)(TSX:ITE), an independent oil and gas company with assets and operations in the UK and Canada, announces that the court order cancelling i3 Energy's deferred A shares (issued in conjunction with the share capital reduction, as previously announced by the Company on 20 June 2024) and the amount standing to the credit of the share premium account, along with the associated court approved statement of capital, has been delivered to the Registrar of Companies. The Capital Reduction will become effective upon the registration of the court order by the Registrar of Companies, which is expected to occur in the next few days.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 3
Purchase of own shares LONDON, UK / ACCESSWIRE / July 3, 2024 / The Company announces that on 02 July 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Poolbeg Pharma PLC Announces Change of Registered Address
Change of Registered Address LONDON, UK / ACCESSWIRE / July 2, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that the Company has changed its registered address to 40 Bank Street, Floor 24, London, E14 5NR, United Kingdom. Enquiries Poolbeg Pharma Plc Jeremy Skillington, CEO Ian O'Connell, CFO +44 (0) 207 183 1499 Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM) +44 (0) 207 220 0500 Shore Capital Stockbrokers Ltd (Joint Broker) David Coaten, Harry Davies-Ball (Corporate Advisory), Malachy McEntyre, Isobel Jones (Corporate Broking) +44 (0) 207 408 4090 J&E Davy (Joint Broker) Anthony Farrell, Niall Gilchrist +353 (0) 1 679 6363 Optimum Strategic Communications Nick Bastin, Vici Rabbetts, Elena Bates +44 (0) 208 078 4357 [email protected] About Poolbeg Pharma Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 2
LONDON, UK / ACCESSWIRE / July 2, 2024 / The Company announces that on 01 July 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Argo Blockchain PLC Announces Loan Extension
Extension of Galaxy Loan LONDON, UNITED KINGDOM / ACCESSWIRE / July 1, 2024 / Argo Blockchain plc, (LSE:ARB)(NASDAQ:ARBK), a global leader in cryptocurrency mining using predominantly renewable energy, announces the extension of its loan with Galaxy Digital Holdings Ltd. ("Galaxy") through to December 28, 2024.
Ecora Resources PLC Announces Acquisition of Royalty over Phalaborwa Project
Acquisition of royalty over the Phalaborwa rare earths project LONDON, UNITED KINGDOM / ACCESSWIRE / July 1, 2024 / Ecora (LSE:ECOR)(TSX:ECOR) announces that it has entered into an agreement to acquire a 0.85% Gross Revenue Royalty ("GRR") over the Phalaborwa Rare Earths Project ("Phalaborwa" or the "Project") located in South Africa for a total cash consideration of US$8.5 million. In connection with the royalty acquisition and in addition to the cash consideration, Ecora has subscribed for 10,442,427 new ordinary shares in Rainbow Rare Earths Ltd ("Rainbow"), the majority owner of the Phalaborwa project, for US$1.5 million in cash.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 1
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / July 1, 2024 / The Company announces that on 28 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Jun 28
Purchase of own shares LONDON, UK / ACCESSWIRE / June 28, 2024 / The Company announces that on 27 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed on a show of hands. The numbers of proxy votes for each resolution submitted prior to the meeting are presented below.
